NLRP3 and chronic kidney disease: In one of these studies, it was shown that the absence of Nlrp3 led to a classical reduction of caspase-1 activation and maturation of IL-1β and IL-18 and diminished renal inflammation and injury in the late phase of experimental chronic kidney disease [10].